AC Immune SA
(ACIU)
undefined
undefined%
At close: undefined
2.98
0.34%
After-hours Jan 06, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -54.23M | -70.75M | -73.00M | -61.92M | 45.44M | -50.95M | -26.41M | -7.10M | 20.27M | 10.74M | -11.24M |
| Depreciation & Amortization | 2.21M | 2.36M | 2.41M | 1.97M | 1.69M | 961.00K | 580.00K | 278.00K | 287.00K | 298.00K | 293.00K |
| Stock-Based Compensation | 4.37M | 3.33M | 4.13M | 4.09M | 2.83M | 2.52M | 1.58M | 1.32M | 540.00K | 210.00K | 256.00K |
| Other Working Capital | -360.00K | -8.47M | 6.94M | -4.55M | 5.72M | 1.81M | 863.00K | 706.00K | 24.73M | -29.21M | -164.00K |
| Other Non-Cash Items | 2.40M | -72.00K | -6.20M | 551.00K | -909.00K | 1.45M | 3.97M | -3.36M | -1.65M | -27.00K | -9.00M |
| Deferred Income Tax | n/a | n/a | 130.00K | 371.00K | 509.00K | 131.00K | 177.00K | -83.00K | 49.00K | 17.00K | n/a |
| Change in Working Capital | -15.16M | -8.43M | 6.84M | -4.57M | 5.65M | 1.81M | -1.99M | 3.30M | 24.58M | -28.87M | -109.00K |
| Operating Cash Flow | -60.41M | -73.57M | -65.69M | -59.52M | 55.22M | -44.08M | -22.09M | -5.65M | 44.08M | -17.62M | -19.80M |
| Capital Expenditures | -801.00K | -1.24M | -2.63M | -1.71M | -1.89M | -1.86M | -1.80M | -899.00K | -244.00K | -128.00K | -249.00K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | -65.00M | -30.00M | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 66.45M | 25.00M | -51.03M | 30.04M | -65.00M | -178.00K | -40.00K | n/a | n/a | -3.00K | n/a |
| Investing Cash Flow | 65.64M | 23.76M | -53.66M | 28.33M | -66.89M | -32.04M | -1.84M | -899.00K | -244.00K | -131.00K | -249.00K |
| Debt Repayment | -548.00K | -569.00K | 22.95M | -432.00K | 50.06M | 198.00K | 200.00K | n/a | 55.00K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | -100.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | -776.00K | -6.00K | -371.00K | -441.00K | -2.35M | 71.00K | 9.10M | 27.72M | 9.80M | 10.01M |
| Financial Cash Flow | 43.25M | -1.35M | 40.75M | -803.00K | 49.62M | 109.38M | 271.00K | 78.79M | 27.78M | 9.80M | 10.01M |
| Net Cash Flow | 46.91M | -50.63M | -78.68M | -32.69M | 37.13M | 32.09M | -27.83M | 75.69M | 73.22M | -7.95M | -9.85M |
| Free Cash Flow | -61.21M | -74.81M | -68.32M | -61.22M | 53.34M | -45.94M | -23.90M | -6.54M | 43.84M | -17.75M | -20.05M |